Autoimmunity and benefit from trastuzumab treatment in breast cancer: Results from the HERA phase III trial

A. Sonnenblick, A. Bailey, B. Uziely, M. Untch, I. Smith, L. Gianni, J. Baselga, C. Jackisch, D. Cameron, R. Bell, D. Zardavas, N. Al-Sakaff, R. Gelber, M. Dowsett, B. Leyland-Jones, M. Piccart, E. De azambuja

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)viii70
JournalAnnals of Oncology
Publication statusPublished - 1 Oct 2018

Cite this